Brennan, Paul Anthony — Insider Profile

Insider Profile

Brennan, Paul Anthony

🔒 Follow — get an alert on any new filing

$EPRX

Companies Filed At

Open-Market Buys (2yr)

$144K

Buy Value (2yr, open-market)

Jan 23, 2026

Most Recent Trade

Credibility
Score

75%

Hit Rate

+46.6%

Avg 90d Return

+51.2%

Median 90d Return

Evaluated Trades

+90.2%

Best Trade

-6.3%

Worst Trade

Hit rate and returns are based on 4 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Cross-Company Track Record

100%

Hit Rate · 90d

+20.4%

Median Alpha · 90d

Closed Buys Evaluated

100%

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

cluster buyer high frequency size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 6 closed buys with individual return outcomes available on the Research plan.

Political Donations · Elections Canada

$2K in individual political contributions across 3 donations (2013–2023).

Date	Party	Recipient	Amount
2023-12-29	Conservative Party of Canada	Conservative Party of Canada	$400
2015-12-29	Conservative Party of Canada	Conservative Party of Canada	$750
2013-12-30	Conservative Party of Canada	Conservative Party of Canada	$751

Source: Elections Canada public contribution records (individual donations only; corporate political donations have been banned federally since 2007). Matched to this insider by name — shown for transparency, not a claim of wrongdoing and not a Confluence Score input.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Jan 23, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	5,000	$11.20	$56K	62
Jan 23, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	5,000	$11.20	$56K	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	24,000	$8.63	$207K	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	24,000	$8.63	$207K	62
Nov 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	7,000	$8.81	$62K	62
Nov 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	4,800	$8.80	$42K	62
Nov 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	1,500	$8.85	$13K	62
Nov 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	3,000	$8.90	$27K	62
Mar 25, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	70,000	$5.14	$360K	62
May 13, 2024	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	70,000	$3.96	$277K	62
Aug 18, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Sell	5,000	$7.00	$35K	62
Mar 30, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	900	$4.14	$4K	62
Mar 29, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	9,100	$4.10	$37K	62

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.